Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.356
Sell
RSI(14)
22.907
Sell
STOCH(KDJ)(9,3,3)
19.277
Neutral
ATR(14)
1.538
High Vlolatility
CCI(14)
-150.439
Sell
Williams %R
72.903
Sell
TRIX(12,20)
-0.873
Sell
StochRSI(14)
0.000
Oversold
SNWV
SNWV17.080USD
-1.770-9.39%
Market hours （ET）Quotes delayed by 15 min
952.27KMarket Cap
12.29P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of SNWV
Currency: USD Updated: 2026-03-27Key Insights
SANUWAVE Health Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 80 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 54.00.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
SNWV's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
SNWV Highlights
StrengthsRisks
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 115.96% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 44.05M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 13.39, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 4.37M shares, decreasing 11.47% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 445.21K shares of this stock.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
43.500
Target Price
+130.77%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-03-27The current financial score of SANUWAVE Health Inc is 7.11, ranking 87 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 13.09M, representing a year-over-year increase of 26.81%, while its net profit experienced a year-over-year increase of 148.60%.
Score
Financials
6.26
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.60
Operational Efficiency
8.54
Growth Potential
7.01
Shareholder Returns
7.15
SNWV's Company Valuation
Currency: USD Updated: 2026-03-27The current valuation score of SANUWAVE Health Inc is 6.73, ranking 153 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 13.39, which is 0.00% below the recent high of 13.39 and 614.03% above the recent low of -68.85.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 80/208
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-03-27The current earnings forecast score of SANUWAVE Health Inc is 8.00, ranking 61 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 54.00, with a high of 55.00 and a low of 53.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
43.500
Target Price
+130.77%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
115
Total
6
Median
9
Average
Company name
Ratings
Analysts
SNWV
2
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-03-27The current price momentum score of SANUWAVE Health Inc is 6.74, ranking 71 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 23.91 and the support level at 15.01, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
19.612
Sell
MA10
20.405
Sell
MA20
21.639
Sell
MA50
24.083
Sell
MA100
27.712
Sell
MA200
31.540
Sell
Institutional Confidence
Currency: USD Updated: 2026-03-27Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Opaleye Management Inc.
Manchester Management Company, L.L.C.
AWM Investment Company, Inc.
BlackRock Institutional Trust Company, N.A.
Solas Capital Management, LLC
Geode Capital Management, L.L.C.
State Street Investment Management (US)
1
2
Risk Assessment
Currency: USD Updated: 2026-03-27The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of SANUWAVE Health Inc is 4.11, ranking 111 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.47. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.49
VaR
+13.93%
240-Day Maximum Drawdown
+58.64%
240-Day Volatility
+78.88%
Return
Best Daily Return
60 days
+4.41%
120 days
+17.68%
5 years
+5614.29%
Worst Daily Return
60 days
-6.08%
120 days
-21.58%
5 years
-98.25%
Sharpe Ratio
60 days
-5.22
120 days
-1.90
5 years
+0.51
Risk Assessment
Maximum Drawdown
240 days
+58.64%
3 years
--
5 years
--
Return-to-Drawdown Ratio
240 days
-0.64
3 years
--
5 years
--
Skewness
240 days
+0.16
3 years
+0.99
5 years
+34.16
Volatility
Realised Volatility
240 days
+78.88%
5 years
--
Standardised True Range
240 days
+11.32%
5 years
--
Downside Risk-Adjusted Return
120 days
-255.49%
240 days
-255.49%
Maximum Daily Upside Volatility
60 days
+36.56%
Maximum Daily Downside Volatility
60 days
+33.63%
Liquidity
Average Turnover Rate
60 days
+0.97%
120 days
+0.79%
5 years
--
Turnover Deviation
20 days
--
60 days
--
120 days
--
Peer Comparison
Healthcare Equipment & Supplies
SNWV
6.65 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
BVS
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.05 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
